Pharmacologically, a novel small molecule kinase inhibitor of ROCK1/2 that preferentially accumulated in liver tissue ameliorated insulin resistance and decreased liver injury, inflammation, and fibrosis in mice fed the FFC NASH diet. The gene discussed is ROCK1; the disease is Insulin resistance.